Aidan Power
Non-Executive Chairman
Healthcare
Bilcare Research
Antigua and Barbuda
Biography
Power brings to Alzheon over twenty years of drug development. Previously, Dr. Power was Vice President and Head of PharmaTherapeutics Precision Medicine at Pfizer Global Research and Development in New London, CT, where he led a diverse group providing genomics, genetics and imaging expertise to projects across Cardiovascular, Neurosciences and Pain therapeutic areas, supporting novel target identification, biomarker development and precision medicine strategies for early stage clinical programs. Dr. Power led major external partnerships at Pfizer including Yale/Pfizer Bioimaging Alliance and Pfizer/NIH/NCATS’ New Therapeutic Uses Initiative, and his group developed and delivered successful collaborations with major academic institutions including University of Cambridge, Karolinska Institutet, University College London, and Washington U
Research Interest
Power brings to Alzheon over twenty years of drug development. Previously, Dr. Power was Vice President and Head of PharmaTherapeutics Precision Medicine at Pfizer Global Research and Development in New London, CT, where he led a diverse group providing genomics, genetics and imaging expertise to projects across Cardiovascular, Neurosciences and Pain therapeutic areas, supporting novel target identification, biomarker development and precision medicine strategies for early stage clinical programs. Dr. Power led major external partnerships at Pfizer including Yale/Pfizer Bioimaging Alliance and Pfizer/NIH/NCATS’ New Therapeutic Uses Initiative, and his group developed and delivered successful collaborations with major academic institutions including University of Cambridge, Karolinska Institutet, University College London, and Washington U
